Blair William & CO Accelerate Diagnostics, Inc Transaction History

Blair William & CO

$32 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.51 - $17.1 $63,067 - $2.11 Million	-123,662 Reduced 72.94%	45,881 $32,000
Q3 2022 Nov 09, 2022	BUY	$1.01 - $17.0 $115,746 - $1.95 Million	114,600 Added 208.58%	169,543 $258,000
Q2 2022 Aug 10, 2022	SELL	$0.54 - $1.41 $330,564 - $863,141	-612,157 Reduced 91.76%	54,943 $55,000
Q1 2022 May 13, 2022	SELL	$1.4 - $5.15 $10,080 - $37,080	-7,200 Reduced 1.07%	667,100 $961,000
Q4 2021 Feb 14, 2022	SELL	$4.27 - $6.97 $866,327 - $1.41 Million	-202,887 Reduced 23.13%	674,300 $3.52 Million
Q3 2021 Nov 12, 2021	BUY	$5.31 - $8.25 $141,230 - $219,425	26,597 Added 3.13%	877,187 $5.11 Million
Q2 2021 Aug 12, 2021	SELL	$6.81 - $9.23 $24,795 - $33,606	-3,641 Reduced 0.43%	850,590 $6.86 Million
Q1 2021 May 13, 2021	BUY	$7.99 - $15.0 $4.71 Million - $8.85 Million	589,724 Added 222.95%	854,231 $7.11 Million
Q4 2020 Feb 09, 2021	SELL	$7.04 - $11.7 $1.74 Million - $2.89 Million	-246,947 Reduced 48.28%	264,507 $2.01 Million
Q3 2020 Nov 06, 2020	SELL	$9.98 - $18.04 $208,033 - $376,043	-20,845 Reduced 3.92%	511,454 $5.45 Million
Q2 2020 Aug 12, 2020	SELL	$7.49 - $15.16 $25,271 - $51,149	-3,374 Reduced 0.63%	532,299 $8.07 Million
Q1 2020 May 11, 2020	SELL	$4.62 - $18.74 $45,400 - $184,157	-9,827 Reduced 1.8%	535,673 $4.46 Million
Q4 2019 Feb 13, 2020	SELL	$14.6 - $18.13 $3.78 Million - $4.69 Million	-258,916 Reduced 32.19%	545,500 $9.22 Million
Q3 2019 Nov 12, 2019	BUY	$16.62 - $23.92 $799,754 - $1.15 Million	48,120 Added 6.36%	804,416 $14.9 Million
Q2 2019 Aug 13, 2019	BUY	$17.79 - $22.88 $1.1 Million - $1.41 Million	61,774 Added 8.89%	756,296 $17.3 Million
Q1 2019 May 14, 2019	BUY	$11.76 - $22.15 $645,118 - $1.22 Million	54,857 Added 8.58%	694,522 $14.6 Million
Q4 2018 Feb 14, 2019	SELL	$10.42 - $21.94 $2.49 Million - $5.24 Million	-238,990 Reduced 27.2%	639,665 $7.36 Million
Q3 2018 Nov 13, 2018	BUY	$20.4 - $24.6 $4.76 Million - $5.74 Million	233,408 Added 36.17%	878,655 $20.2 Million
Q2 2018 Aug 13, 2018	BUY	$19.02 - $24.95 $272,043 - $356,859	14,303 Added 2.27%	645,247 $14.4 Million
Q1 2018 May 15, 2018	SELL	$22.55 - $29.9 $8.77 Million - $11.6 Million	-388,819 Reduced 38.13%	630,944 $14.4 Million
Q4 2017 Feb 14, 2018	BUY	$18.0 - $30.0 $1.3 Million - $2.17 Million	72,470 Added 7.65%	1,019,763 $26.7 Million
Q3 2017 Nov 13, 2017	BUY	$21.1 - $25.15 $20 Million - $23.8 Million	947,293	947,293 $21.3 Million

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account